Late Coronary Stent Thrombosis Complicating Urologic Surgery

European Urology

Volumn 54, Issue 1, 2008, Pages 221-225

  de Korte, Fleur I ^a   van Werkum, Jochem W ^a   Vijverberg, Peter L M ^a   ten Berg, Jurriën M ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Coronary stents; Thrombosis; Urologic surgical procedures adverse effects

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL;

AGED; CASE REPORT; CLINICAL PRACTICE; CORONARY ARTERY THROMBOSIS; DECISION MAKING; DRUG ELUTING STENT; DRUG WITHDRAWAL; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREOPERATIVE CARE; PRIORITY JOURNAL; RESTENOSIS; SHORT SURVEY; TREATMENT WITHDRAWAL; UROLOGIC SURGERY;

AGED; CORONARY STENOSIS; DRUG-ELUTING STENTS; FATAL OUTCOME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPH NODE EXCISION; MALE; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; PROSTATIC NEOPLASMS; THROMBOSIS; TICLOPIDINE; WITHHOLDING TREATMENT;

EID: 44049086670     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.10.005     Document Type: Short Survey

References (11)

1. Eisenberg M.J., and Konnyu K.J. Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis. Am J Cardiol 98 (2006) 375-382
2. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
3. Silber S., Albertsson P., Aviles F.F., et al. Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26 (2005) 804-847
4. Eisenstein E.L., Anstrom K.J., Kong D.F., et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297 (2007) 159-168
5. Hattori T., Khan M.M., Colman R.W., and Edmunds Jr. L.H. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds. J Am Coll Cardiol 46 (2005) 707-713
6. Gottlieb A., Banoub M., Sprung J., Levy P.J., Beven M., and Mascha E.J. Perioperative cardiovascular morbidity in patients with coronary artery disease undergoing vascular surgery after percutaneous transluminal coronary angioplasty. J Cardiothorac Vasc Anesth 12 (1998) 501-506
7. Kaluza G.L., Joseph J., Lee J.R., Raizner M.E., and Raizner A.E. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35 (2000) 1288-1295
8. Eagle K.A., Berger P.B., Calkins H., et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery-Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg 94 (2002) 1052-1064
9. Nielsen J.D., Holm-Nielsen A., Jespersen J., Vinther C.C., Settgast I.W., and Gram J. The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy-a prospective, randomized, double-blind, placebo-controlled study. Scand J Urol Nephrol 34 (2000) 194-198
10. Mehta R.H., Roe M.T., Mulgund J., et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 48 (2006) 281-286
11. Grines C.L., Bonow R.O., Casey D.E., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. Circulation 115 (2007) 813-818